Cargando…
Highlights of the 2018 Chinese hypertension guidelines
BACKGROUND: Blood pressure (BP) are uncontrolled in over 80% hypertensive population in China, indicating a compelling need for a pragmatic hypertension management strategy. The 2018 Chinese hypertension guidelines issued in 2019, after 3 years revision. During the periods, the latest United States...
Autor principal: | Liu, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193361/ https://www.ncbi.nlm.nih.gov/pubmed/32377372 http://dx.doi.org/10.1186/s40885-020-00141-3 |
Ejemplares similares
-
2018 Chinese Guidelines for Prevention and Treatment of Hypertension—A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension
Publicado: (2019) -
Intensified, optimized and standardized management of Chinese patients with hypertension: Comments on “2018 Chinese Guidelines for Prevention and Treatment of Hypertension”
por: Zhang, Wei-Zhong
Publicado: (2019) -
The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
por: Kim, Hack-Lyoung, et al.
Publicado: (2023) -
Tourette syndrome research highlights from 2018
por: Rose, Olivia, et al.
Publicado: (2019) -
Similarities in Hypertension Status but Differences in Mortality Risk: A Comparison of 2017 ACC/AHA and 2018 Chinese Hypertension Guidelines
por: Chen, Kangyu, et al.
Publicado: (2022)